Marie Utter News Today

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has received a consensus recommendation of “Reduce” from the thirteen analysts that are currently covering the firm, Marketbeat reports. Five analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company. The average […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has earned a consensus recommendation of “Reduce” from the fifteen brokerages that are presently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and three have issued a buy recommendation on the company. […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has received a consensus recommendation of “Reduce” from the fifteen ratings firms that are currently covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have assigned a buy recommendation to the […]

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) gapped down prior to trading on Friday after Cantor Fitzgerald lowered their price target on the stock from $51.00 to $45.00. The stock had previously closed at $26.66, but opened at $25.71. Cantor Fitzgerald currently has an overweight rating on the stock. PTC Therapeutics shares […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shares traded down 2.9% on Tuesday . The stock traded as low as $38.61 and last traded at $39.10. 132,714 shares traded hands during trading, a decline of 83% from the average session volume of 801,563 shares. The stock had previously closed at $40.27. Analyst Upgrades and […]

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) have earned an average rating of “Moderate Buy” from the nineteen analysts that are currently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year […]

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its price target decreased by Barclays from $57.00 to $48.00 in a research report sent to investors on Wednesday, The Fly reports. A number of other analysts also recently issued reports on PTCT. William Blair reiterated an outperform rating on shares of PTC Therapeutics in a report on […]

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its target price lowered by stock analysts at Credit Suisse Group from $55.00 to $50.00 in a report issued on Wednesday, The Fly reports. Credit Suisse Group’s price objective would suggest a potential upside of 15.05% from the stock’s current price. PTCT has been the topic of a […]

StockNews.com assumed coverage on shares of PTC Therapeutics (NASDAQ:PTCT – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other research analysts also recently commented on PTCT. Morgan Stanley boosted their price target on PTC Therapeutics from $40.00 to […]

VNET Group restated their maintains rating on shares of PTC Therapeutics (NASDAQ:PTCT – Get Rating) in a research note issued to investors on Thursday morning, Benzinga reports. Several other analysts also recently issued reports on the company. Credit Suisse Group lifted their price target on PTC Therapeutics from $48.00 to $51.00 in a research note […]